Cisplatin is a chemotherapy drug used to treat various cancers, including bladder, testicular, ovarian, and lung cancers [1]. It belongs to a class of drugs called platinum-based antineoplastics [1].
How does Cisplatin work to kill cancer cells?
Cisplatin functions by binding to DNA within cancer cells. This binding interferes with DNA replication and repair, ultimately triggering programmed cell death (apoptosis) in the cancerous cells [1].
What are the common side effects of Cisplatin treatment?
Patients undergoing Cisplatin treatment may experience a range of side effects. These commonly include nausea and vomiting, which can be severe and are often managed with antiemetic medications. Other potential side effects include kidney damage (nephrotoxicity), nerve damage (neurotoxicity) leading to tingling or numbness, hearing loss (ototoxicity), bone marrow suppression resulting in low blood cell counts, fatigue, and hair loss (alopecia) [1].
What is the outlook for Cisplatin patents and exclusivity?
The patent and exclusivity landscape for Cisplatin is complex, as it is a well-established drug. Many of the original patents have expired, making it available as a generic medication [2]. However, specific formulations or combinations involving Cisplatin might still be subject to patent protection. DrugPatentWatch.com tracks patent information for various drugs, including Cisplatin, which can offer insights into remaining exclusivity periods for different versions of the drug [2].
Are there alternatives to Cisplatin for cancer treatment?
Yes, depending on the type and stage of cancer, alternative chemotherapy agents or treatment modalities exist. For some cancers historically treated with Cisplatin, other platinum-based drugs like carboplatin are sometimes used, offering a different side effect profile. Immunotherapy, targeted therapy, and radiation therapy are also options for various cancers [3].
How is Cisplatin administered to patients?
Cisplatin is typically administered intravenously (IV) through an infusion [1]. The dosage and duration of treatment are determined by the specific cancer being treated, its stage, and the patient's overall health [1].